Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics

Journal of Sexual Medicine

Volumn 7, Issue 10, 2010, Pages 3404-3413

  Montejo, Ángel L ^a   Majadas, Susana ^b   Rico Villademoros, Fernando ^c   LLorca, Ginés ^d   de la Gándara, Jesús ^e   Franco, Manuel ^f   Martín Carrasco, Manuel ^g   Aguera, Luis ^h   Prieto, Nieves ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Asociación Española de Sexualidad y Salud Mental   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY OF SALAMANCA   (Spain)

^e HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^f Hospital Provincial de Zamora   (Spain)

^g Instituto de Investigaciones Psiquiatricas   (Spain)

^h HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Antipsychotics; Iatrogenic Sexual Dysfunction; Medication Associated Sexual Dysfunction; Psychosis; Schizophrenia; Sexual Dysfunction

Indexed keywords

CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PIPOTIAZINE PALMITATE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL ACETATE; ZUCLOPENTHIXOL DECANOATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INCIDENCE; LONG TERM CARE; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; QUESTIONNAIRE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT DURATION;

EID: 77957342855     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01709.x     Document Type: Article

References (42)

1. Derogatis LR, Burnett AL. The epidemiology of sexual dysfunctions. J Sex Med 2008, 5:289-300.
2. Nicolosi A, Laumann EO, Glasser DB, Moreira ED, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: The global study of sexual attitudes and behaviors. Urology 2004, 64:991-7. Global Study of Sexual Attitudes and Behaviors Investigators' Group
3. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, Martin-Morales A. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004, 1:35-9.
4. Clayton A, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 2006, 67(6):33-7. suppl
5. Segraves RT, Balon R. Sexual pharmacology. Fast facts 2003, New York, W.W. Norton & Company, Inc.
6. Harley EW, Boardman J, Craig T. Sexual problems in schizophrenia: Prevalence and characteristics. A cross sectional survey. Soc Psychiatry Psychiatr Epidemiol 2009, Aug 22 [Epub ahead of print] doi: 10.1007/s00127-009-0119-0
7. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002, 181:49-55.
8. Bobes J, Garcia-Portilla MP, Rejas J, Hernandez G, Garcia-Garcia M, Rico-Villademoros F, Porras A. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: The results of the EIRE study. J Sex Marital Ther 2003, 29:125-47.
9. Knegtering R, Castelein S, Bous H, Van Der Linde J, Bruggeman R, Kluiter H, van den Bosch RJ. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol 2004, 24:56-61.
10. Knegtering H, Boks M, Blijd C, Castelein S, van den Bosch RJ, Wiersma D. A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Marital Ther 2006, 32:315-26.
11. Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmüller D, Lemke MR, Maier W, Schubert M, Sträter B, Kühn KU. Prolactin, subjective well-being and sexual dysfunction: An open label observational study comparing quetiapine with risperidone. J Sex Med 2008, 5:2816-26.
12. Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Schmidt F, Lewis R, Kissling W, Leucht S. Sertindole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2009, (2). CD006752
13. Montejo Gonzalez AL, Rico-Villademoros F, Tafalla M, Majadas S. A 6-month prospective observational study on the effects of quetiapine on sexual functioning. J Clin Psychopharmacol 2005, 25:533-8. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction
14. Montejo AL, Rico-Villademoros F. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: A 3-month prospective, observational study. J Clin Psychopharmacol 2008, 28:568-70. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction
15. Hanssens L, L'Italien G, Loze JY, Marcus RN, Pans M, Kerselaers W. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: Results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry 2008, 8:95.
16. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker WW. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 1999, 156:631-3.
17. Bitter I, Basson BR, Dossenbach MR. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 2005, 20:19-21.
18. Fan X, Henderson DC, Chiang E, Briggs LB, Freudenreich O, Evins AE, Cather C, Goff DC. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res 2007, 94:119-27.
19. Olfson M, Uttaro T, Carson WH, Tafesse E. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry 2005, 66:331-8.
20. Westheide J, Cohen S, Bender S, Cooper-Mahkorn D, Erfurth A, Gastpar M, Huber TJ, Maier W, Murafi A, Rothermund M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Kühn KU. Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. Pharmacopsychiatry 2007, 40:140-5.
21. Weiden PJ, Miller AL. Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J Psychiatr Pract 2001, 7:41-7.
22. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 2001, 16:153-62.
23. Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 2004, 19:415-22.
24. Bebbington PE, Angermeyer M, Azorin JM, Marwaha S, Marteau F, Toumi M. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia. Acta Psychiatr Scand Suppl 2009, 22-8.
25. Ritsner M, Ponizovsky A, Endicott J, Nechamkin Y, Rauchverger B, Silver H, Modai I. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: A naturalistic study. Eur Neuropsychopharmacol 2002, 12:31-8.
26. Weiden PJ, Mackell JA, McDonnell DD. Sexual dysfunction and adherence to antipsychotic therapy. Paper presented at: 23rd Congress of the Collegium Internationale Neuro-psychopharmacologicum; June 26, 2002; Montreal, QC, Canada
27. Rosenberg KP, Bleiberg KL, Koscis J, Gross C. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: Impact on compliance. J Sex Marital Ther 2003, 29:289-96.
28. Montejo AL, Garcia M, Espada M, Rico-Villademoros F, Llorca G, Izquierdo JA. Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions. Actas Esp Psiquiatr 2000, 28:141-50.
29. Montejo AL, Rico-Villademoros F. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther 2008, 34:227-39. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction
30. Üçok A, Incesu C, Aker T, Erkoc S. Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry 2007, 22:328-33.
31. Dossenbach M, Hodge A, Anders M, Molnár B, Peciukaitiene D, Krupka-Matuszczyk I, Tatu M, Bondar V, Pecenak J, Gorjanc T, McBride M. Prevalence of sexual dysfunction in patients with schizophrenia: International variation and underestimation. Int J Neuropsychopharmacol 2005, 8:195-201.
32. Ucok A, Incesu C, Aker T, Erkoc S. Do psychiatrists examine sexual dysfunction in schizophrenia patients? J Sex Med 2008, 5:2000-1.
33. Dickey B, Normand SL, Eisen S, Hermann R, Cleary P, Cortés D, Ware N. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences. Med Care 2006, 44:827-34.
34. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995, 56:137-41.
35. Plevin D, Galletly C, Roughan P. Sexual dysfunction in men treated with depot antipsychotic drugs: A pilot study. Sex Health 2007, 4:269-71.
36. Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian cohort: Prevalence and risk factors. Eur Urol 2005, 47:366-74.
37. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001, 62(3):10-21. suppl
38. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006, 21:251-8.
39. Lambert T, Brennan A, Castle D, Kelly DL, Conley RR. Perception of depot antipsychotics by mental health professionals. J Psychiatr Pract 2003, 9:252-60.
40. Montejo AL. Prolactin awareness: An essential consideration for physical health in schizophrenia. Eur Neuropsychopharmacol 2008, 18(2):S108-14. suppl
41. Balon R, Segraves RT. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. J Sex Marital Ther 2008, 34:353-65.
42. Berner MM, Hagen M, Kriston L. Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev 2007, (1). CD003546